Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death in Canada and may affect up to as many as 3 million Canadians. However, due to inadequate diagnostic tools, 50% remain undiagnosed. Furthermore, COPD patients also suffer attacks, or exacerbations, which can hospitalise the patient, worsen their condition and take weeks to recover from. Exacerbations are difficult to predict and it is even harder to identify which patients are more susceptible to repeated attacks. I will investigate a group of small molecules, microRNAs, in patient blood, in order to identify which specific miRNAs are associated with COPD exacerabations and to identify whith patients are more susceptible to repeated exacerbations. Ultimately these findings will allow researchers a better insight into the mechanisms of COPD exacerbations, which in turn will lead to improved predictive and diagnostic tools and allow doctors to tailor patient management and reduce future lung attacks.
Scott Tebbutt
St Paul's Hospital
Life Sciences
Health and Related Sciences & Technology
The University of British Columbia
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.